Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$123 Hold
20
﹤0.01% 4125
2026
Q1
$99 Hold
20
﹤0.01% 4130
2025
Q4
$117 Hold
20
﹤0.01% 3994
2025
Q3
$121 Hold
20
﹤0.01% 3959
2025
Q2
$78 Hold
20
﹤0.01% 4119
2025
Q1
$62 Hold
20
﹤0.01% 4148
2024
Q4
$106 Hold
20
﹤0.01% 4108
2024
Q3
$92 Hold
20
﹤0.01% 4036
2024
Q2
$142 Hold
20
﹤0.01% 3921
2024
Q1
$170 Hold
20
﹤0.01% 3915
2023
Q4
$119 Hold
20
﹤0.01% 3918
2023
Q3
$198 Hold
20
﹤0.01% 3910
2023
Q2
$352 Hold
20
﹤0.01% 3899
2023
Q1
$452 Hold
20
﹤0.01% 3964
2022
Q4
$400 Sell
20
-22
-52% -$510 ﹤0.01% 4027
2022
Q3
$2K Hold
42
﹤0.01% 3806
2022
Q2
$2K Hold
42
﹤0.01% 3805
2022
Q1
$4K Hold
42
﹤0.01% 3658
2021
Q4
$4K Buy
+42
New +$4.49K ﹤0.01% 3699

Other funds holding CLNN

US Bancorp's CLNN Position: Q2 2026 in Review

US Bancorp held its Clene (CLNN) position steady in Q2 2026 at 20 shares worth $123. The position accounts for ﹤0.01% of the portfolio, ranked #4125.

US Bancorp first reported a position in CLNN in Q4 2021 and has held it in 19 quarters since. The position peaked at $4K in Q1 2022. 21 funds tracked by Wall St. Rank hold CLNN as of Q2 2026.

  • US Bancorp held 20 shares of Clene worth $123 as of Q2 2026.
  • US Bancorp left its Clene share count unchanged in Q2 2026.
  • Clene made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #4125 holding.
  • US Bancorp first reported a position in Clene in Q4 2021 and has held it in 19 quarters since.
  • US Bancorp's Clene position peaked at $4K in Q1 2022.
  • 21 funds tracked by Wall St. Rank held Clene as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.